Browsing Tag
Ajanta Pharma
2 posts
Is Jagsonpal Pharmaceuticals’ asset-light model a blueprint for mid-cap pharma growth in India?
Jagsonpal Pharmaceuticals’ asset-light model, zero-debt balance sheet, and 23% ROE show how mid-cap Indian pharma firms can grow without heavy capex.
Ajanta Pharma secures FDA approval for Topiramate Capsules, eyes 2026 market launch
Ajanta Pharma Limited, a leading specialty pharmaceutical formulation company, has won a decisive victory by gaining final approval…